Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial

Clinical Endocrinology

Volumn 63, Issue 3, 2005, Pages 323-328

  Wakelkamp, Iris M M J ^a,b   Baldeschi, L ^a   Saeed, P ^a   Mourits, M P ^a   Prummel, M F ^a   Wiersinga, W M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CHEMOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECOMPRESSION SURGERY; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL ACUITY;

ACUTE DISEASE; ADULT; DECOMPRESSION, SURGICAL; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PREDNISOLONE; PULSE THERAPY, DRUG; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 24144445600     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02345.x     Document Type: Article

References (24)

1. Prummel, M.F., Bakker, A., Wiersinga, W.M., Baldeschi, L., Mourits, M.P., Kendall-Taylor, P., Perros, P., Neoh, C., Dickinson, A. J., Lazarus, J.H., Lane, C.M., Heufelder, A.E., Kahaly, G.J., Pitz, S., Orgiazzi, J., Hullo, A., Pinchera, A., Marcocci, C., Sartini, M.S., Rocchi, R., Nardi, M., Krassas, G.E. & Halkias, A. (2003) Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. European Journal of Endocrinology, 148, 491-495.
2. Bartalena, L., Wiersinga, W.M. & Pinchera, A. (2004) Graves' ophthalmopathy: state of the art and perspectives. Journal of Endocrinological Investigation, 27, 295-301.
3. Bahn, R.S., Hartley, G.B. & Gorman, C.A. (1992) Emergency treatment of Graves' ophthalmopathy. Bailliere's Clinical Endocrinology and Metabolism, 6, 95-105.
4. Otto, A.J., Koornneef, L., Mounts, M.P. & Deen-Van Leeuwen, L. (1996) Retrobulbar pressures measured during surgical decompression of the orbit. British Journal of Ophthalmology, 80, 1042-1045.
5. Bartalena, L., Marcocci, C. & Pinchera, A. (1997) Graves ophthalmopathy, glucocorticoids, orbital radiotherapy, cytokines, plasmapheresis, orbital decompression, immunosuppressive, drugs and immunoglobulins. Treating severe Graves' ophthalmopathy. Bailliere's Clinical Endocrinology and Metabolism, 11, 521-536.
6. Prummel, M.F., Mourits, M.P., Berghout, A., Krenning, E.P., Van der Gaag, R., Koornneef, L. & Wiersinga, W.M. (1989) Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. New England Journal of Medicine, 321, 1353-1359.
7. Prummel, M.F., Mourits, M.P., Blank, L., Berghout, A., Koornneef, L. & Wiersinga, W.M. (1993) Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet, 342, 949-954.
8. Nagayama, Y., Izumi, M., Kiriyama, T., Yokoyama, N., Morita, S., Kakezono, F., Ohtakara, S., Morimoto, I., Okamoto, S. & Nagataki, S. (1987) Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy. Acta Endocrinologica, 116, 513-518.
9. Hallin, E.S., Feldon, S.E. & Luttrell, J. (1988) Graves' ophthalmopathy: III. Effect of transantral orbital decompression on optic neuropathy. British Journal of Ophthalmology, 72, 683-687.
10. Kendall-Taylor, P., Crombie, A.L., Stephenson, A.M., Hardwick, M. & Hall, K. (1988) Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. British Medical Journal, 297, 1574-1578.
11. Marcocci, C., Bartalena, L., Tanda, M.L., Manetti, L., Dell'Unto, E., Rocchi, R., Barbesino, G., Mazzi, B., Bartolomei, M.P., Lepri, P., Cartei, F., Nardi, M. & Pinchera, A. (2001) Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. Journal of Clinical Endocrinology and Metabolism, 86, 3562-3567.
12. Kauppinen-Makelin, R., Karma, A., Leinonen, E., Loyttyniemi, E., Salonen, O., Sane, T., Setala, K., Viikari, J., Heufelder, A. & Valimaki, M. (2002) High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmologica Scandinavica, 80, 316-321.
13. Gorman, C.A., DeSanto, L.W., MacCarty, C.S. & Riley, EC. (1974) Optic neuropathy of Graves's disease. Treatment by transantral or transfrontal orbital decompression. New England Journal of Medicine, 290, 70-75.
14. Mourits, M.P., Koornneef, L., Wiersinga, W.M., Prummel, M.F., Berghout, A. & Van der Gaag, R. (1990) Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology, 97, 636-641.
15. Garrity, J.A., Fatourechi, V., Bergstralh, E.J., Bartley, G.B., Beatty, C.W., DeSanto, L.W. & Gorman, C.A. (1993) Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. American Journal of Ophthalmology, 116, 533-547.
16. Soares-Welch, C.V., Fatourechi, V., Bartley, G.B., Beatty, C.W., Gorman, C.A., Bahn, R.S., Bergstralh, E.J., Schleck, C.D. & Garrity, J.A. (2003) Optic neuropathy of graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients. American Journal of Ophthalmology, 136, 433-441.
17. Gorman, C.A. & Bahn, R.S. (1989) Pathogenesis of Graves' ophthalmopathy. In: C. Pickardt, K. Boergen eds. Graves' Ophthalmopathy. Developments in Diagnostic Methods and Therapeutical Procedures. Karger, New York, 1-7.
18. Mounts, M.P., Prummel, M.F., Wiersinga, W.M. & Koornneef, L. (1997) Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology, 47, 9-14.
19. Wiersinga, W.M. & Chopra, I.J. (1982) Radioimmunoassay of thyroxine (T4), 3,5,3′-triiodothyronine (T3), 3,3′,5′-triiodothyronine (reverse T3, rT3), and 3,3′-diiodothyronine (T2). Methods in Enzymology, 84, 272-303.
20. Mourits, M.P., Prummel, M.F., Wiersinga, W.M. & Koornneef, L. (1994) Measuring eye movements in Graves ophthalmopathy. Ophthalmology, 101, 1341-1346.
21. Gorman, C.A. (1998) The measurement of change in Graves' ophthalmopathy. Thyroid, 8, 539-543.
22. Kalmann, R., Mourits, M.P., van der Pol, J.P. & Koornneef, L. (1997) Coronal approach for rehabilitative orbital decompression in Graves' ophthalmopathy. British Journal of Ophthalmology, 81, 41-45.
23. Baldeschi, L., Lupetti, A., Wakelkamp, I.M.M.J., Prummel, M.F. & Wiersinga, W.M. (2004) Reactivation of Graves' orbitopathy after aesthetic orbital decompression. European Society of Ophthalmic Plastic and Reconstructive Surgery, 22nd Annual Meeting, June 17-19, Leuven, Belgium.
24. Marino, M., Morabito, E., Brunetto, M.R., Bartalena, L., Pinchera, A. & Marocci, C. (2004) Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves' ophthalmopathy. Thyroid, 14, 403-406.